Abstract:The heart is a functional syncytium controlled by a delicate and sophisticated balance ensured by the tight coordination of its several cell subpopulations. Accordingly, cardiomyocytes together with the surrounding microenvironment participate in the heart tissue homeostasis. In the right atrium, the sinoatrial nodal cells regulate the cardiac impulse propagation through cardiomyocytes, thus ensuring the maintenance of the electric network in the heart tissue. Notably, the central nervous system (CNS) modulates the cardiac rhythm through the two limbs of the autonomic nervous system (ANS): the parasympathetic and sympathetic compartments. The autonomic nervous system exerts non-voluntary effects on different peripheral organs. The main neuromodulator of the Sympathetic Nervous System (SNS) is norepinephrine, while the principal neurotransmitter of the Parasympathetic Nervous System (PNS) is acetylcholine. Through these two main neurohormones, the ANS can gradually regulate cardiac, vascular, visceral, and glandular functions by turning on one of its two branches (adrenergic and/or cholinergic), which exert opposite effects on targeted organs. Besides these neuromodulators, the cardiac nervous system is ruled by specific neuropeptides (neurotrophic factors) that help to preserve innervation homeostasis through the myocardial layers (from epicardium to endocardium). Interestingly, the dysregulation of this neuro-signaling pathway may expose the cardiac tissue to severe disorders of different etiology and nature. Specifically, a maladaptive remodeling of the cardiac nervous system may culminate in a progressive loss of neurotrophins, thus leading to severe myocardial denervation, as observed in different cardiometabolic and neurodegenerative diseases (myocardial infarction, heart failure, Alzheimer's disease). This review analyzes the current knowledge on the pathophysiological processes involved in cardiac nervous system impairment from the perspectives of both cardiac disorders and a widely diffused and devastating neurodegenerative disorder, Alzheimer's disease, proposing a relationship between neurodegeneration, loss of neurotrophic factors, and cardiac nervous system impairment. This overview is conducive to a more comprehensive understanding of the process of cardiac neuro-signaling dysfunction, while bringing to light potential therapeutic scenarios to correct or delay the adverse cardiovascular remodeling, thus improving the cardiac prognosis and quality of life in patients with heart or neurodegenerative disorders.

Neuroimmune axis of cardiovascular control: mechanisms and therapeutic implications

Brain Cytokines As Neuromodulators In Cardiovascular Control

Heart brain axis in health and disease: role of innate and adaptive immunity

The gut-brain vascular axis in neuroinflammation

The Brain-Heart Axis: Neuroinflammatory Interactions in Cardiovascular Disease

Neuroimmune modulation for targeting organ damage in hypertension and atherosclerosis

Neuroimmune cardiovascular interfaces control atherosclerosis

Neurocardiac Axis Physiology and Clinical Applications

Regulation of cardiac function by the autonomic nervous system

Neurocardiology: translational advancements and potential

Navigating the Neuroimmunomodulation Frontier: Pioneering Approaches and Promising Horizons-A Comprehensive Review

Editorial: Insights in Cardiovascular Therapeutics 2022—cardiovascular Innate Immunity

Autonomic nervous system and cardiac neuro-signaling pathway modulation in cardiovascular disorders and Alzheimer's disease

Neuromodulation by the immune system: a focus on cytokines

[Research Advances of Autonomic Nervous System in the Regulation of Cardiac Inflammation].

Peripheral and central regulation of neuro-immune crosstalk

Neuroimmune cross-talk in heart failure

Neurohumoral Cardiac Regulation: Optogenetics Gets Into the Groove

Neuro-Immune Circuits Regulate Immune Responses in Tissues and Organ Homeostasis

Novel Therapeutics and Upcoming Clinical Trials Targeting Inflammation in Cardiovascular Diseases